InvestorsHub Logo
Followers 70
Posts 9741
Boards Moderated 0
Alias Born 01/21/2007

Re: drchik23 post# 2037

Saturday, 07/23/2011 6:40:57 PM

Saturday, July 23, 2011 6:40:57 PM

Post# of 9287
Nice summary and opinion points but you do not address a couple of important points of the of this FDA approval; it limits the SC tracer to only breast cancer.

Where as NEOP is going after a much broader FDA approval and application also the safety and after affects issues comparing SC to NEOP lympo.

Kels
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NAVB News